Solution

We offer a specialized suite of products and testing services focused on polyethylene glycol (PEG) allergy and anaphylaxis. Our core offering is the PEG-specific IgE detection kit (Shop – Accurate Data. Precision Medicine.), developed for use with flow cytometry—a highly sensitive method that allows precise identification of PEG-specific immunoglobulin E (IgE) antibodies in human blood samples. In addition to the primary detection kit, we provide essential auxiliary reagents including PEG IgE standards and validated positive and negative controls, ensuring accuracy and reproducibility across laboratory applications. These products are intended for use by trained professionals in equipped laboratory settings with flow cytometry instrumentation.

For individuals with known or suspected PEG hypersensitivity, detecting PEG-specific IgE antibodies using our kit is critical for preventing potentially life-threatening allergic reactions. Exposure to PEG-containing products in PEG-sensitized individuals can trigger immediate hypersensitivity, including anaphylaxis. Early and accurate identification enables patients to avoid PEG-containing products and seek appropriate medical care.

Healthcare professionals should recognize the risks associated with PEG hypersensitivity and incorporate PEG-specific IgE testing into the diagnostic evaluation of suspected cases. Accurate identification of PEG allergy can improve patient safety, support clinical decision-making, and reduce the risk of severe allergic reactions.

For developers and manufacturers of PEG-containing vaccines and therapeutics, understanding the immunogenic potential of PEG is essential. Screening for PEG-specific IgE antibodies during clinical development can help identify at-risk populations and support the design of safer formulations. In the post-market setting, PEG-specific IgE testing can strengthen pharmacovigilance by identifying patients at increased risk of PEG-induced anaphylaxis, enabling personalized treatment decisions, improving adverse event monitoring, and reducing the likelihood of severe allergic reactions. This proactive approach promotes the safer use of PEG-containing products and supports regulatory efforts to minimize drug-induced harm.

Selected clients